Anticancer mechanisms and researches of isothiocyanates

Chinese Journal of Natural Medicines

Volumn 6, Issue 5, 2008, Pages 325-332

  Yuan, Peng ^a   Chen, Bao An ^a   Liu, De Long ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Anticancer; Isothiocyanates; Mechanisms; Researches

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; 3 MORPHOLINOPROPYL ISOTHIOCYANATE; 4 PHENYLBUTYL ISOTHIOCYANATE; 6 (METHYLSULFINYL)HEXYL ISOTHIOCYANATE; 6 PHENYLHEXYL ISOTHIOCYANATE; ANTINEOPLASTIC AGENT; BENZYL ISOTHIOCYANATE; CISPLATIN; CYCLOOXYGENASE 2; DOXORUBICIN; ETHYL 4 ISOTHIOCYANATOBUTANOATE; ISOTHIOCYANIC ACID; ISOTHIOCYANIC ACID DERIVATIVE; PHENETHYL ISOTHIOCYANATE; PHENYLMETHYL ISOTHIOCYANATE; SULFORAPHANE; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CLINICAL TRIAL; DRUG POTENTIATION; DRUG RESEARCH; DRUG SENSITIVITY; ENZYME INHIBITION; EPIGENETICS; HORMONE INHIBITION; HUMAN; IMMUNOMODULATION; NONHUMAN; PROSTATE CANCER; REVIEW;

EID: 54449083761     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.3724/SP.J.1009.2008.00325     Document Type: Review

References (60)

1. Murillo G, Mehta RG. Cruciferous vegetables and cancer prevention [J]. Nutr Cancer, 2001, 41(1-2): 17-28.
2. Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants [J]. Phytochemistry, 2001, 56(1): 5-51.
3. Goosen TC, Mills DE, Hollenberg PF. Effects of benzyl isothiocyanate on rat and human cytochromes P450: Identification of metabolites formed by P450 2B1[J]. Pharmacol Exp Ther, 2001, 296: 198-206.
4. Nakamura Y, Ohigashi H, Masuda S, et al. Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: Correlation of enzyme induction with the formation of reactive oxygen intermediates [J]. Cancer Res, 2000, 60(2): 219-225.
5. Joseph MA, Moysich KB, Freudenheim JL, et al. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk [J]. Nutr Cancer, 2004, 50(2): 206-213.
6. Itoh K, Chiba T, Takahashi S, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements [J]. Biochem Biophys Res Gommun, 1997, 236(2): 313-322.
7. Kwak MK, Itoh K, Yamamoto M, et al. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive Agents: Role of antioxidant response element-like sequences in the nrf2 promoter [J]. Mol Cell Biol, 2002, 22(9): 2883-2892.
8. Cho HY, Jedlicka AE, Reddy SPM, et al. Role of NRF2 in protection against hyperoxic lung injury in mice [J]. Respir Cell Mol Biol, 2002, 26(2): 175-182.
9. Kwak MK, Itoh K, Yamamoto M, et al. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione[J]. Mol Med, 2001, 7(2): 135-145.
10. Zhang YS, Gordon GB. A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway [J]. Mol Cancer Ther, 2004, 3: 885-893.
11. Keum YS, Chang PP-J, Kwon KH, et al. 3-morpholinoproply isothiocyanate (3MP-ITC) is a novel synthetic isothiocyanate that strongly induces the antioxidant response element (ARE)-dependent Nrf2-mediated detoxifying/antioxidant enzymes in vitro and in vivo[J]. Carcinogenesis, 2007,10.1093/carcin/bgm208.
12. Rong Y, Sandhya M, Kevin J. et al. Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity [J]. Cancer Res, 1998, 58: 402-408.
13. Kim H, Kim,EH, EomYW, et al. Sulforaphane sensitizes tumor necrosisFactor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5 [J]. Cancer Res, 2006, 66: 1740-1750.
14. Mi LX, Wang XT, Govind S, et al. The Role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells [J]. Cancer Res, 2007, 67: 6409-6416.
15. Zhang YS, Tang L, Gonzalez V. Selected isothiocyanates rapidly induce growth inhibition of cancer cells [J]. Mol Cancer Ther, 2003, 2: 1045-1052.
16. Suh SJ, Moon SK, Kim CH. Raphanus sativus and its isothiocyanates inhibit vascular smooth muscle cells proliferation and induce G(1) cell cycle arrest [J]. Int Immunopharmacol, 2006, 6(5): 854-861.
17. Chaudhuri D, Orsulic S, Badithe T. Antipro- liferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells [J]. Mol Cancer Ther, 2007, 6(1): 334-345.
18. Horakova K, Jantova S, Stred'ansky M, et al. Ethyl 4-isothiocyanatobutanoate-antiproliferative activity in Vitro and in vivo [J]. Anticancer Drugs, 1993, 4(3): 369-375.
19. 2/M checkpoint activation [J]. J Nutr, 2004, 134: 3121-3126.
20. 2/M phase [J]. Anticancer Drugs, 1993, 4(2): 273-279.
21. Cho SD, Li G, Hu H, et al. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells [J]. Nutr Cancer, 2005, 52(2): 213-224.
22. Srivastava SK, Singh SV. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells [J]. Carcinogenesis, 2004, 5: 1701-1709.
23. Fimognari C, Nusse M, BERTI F, et al. Sulforaphane modulates cell cycle and apoptosis in transformed and non-transformed human T lymphocytes ann [J]. N Y Acad Sci, 2003, 1010: 393-398.
24. Shan Y, Sun C, Zhao X, et al. Effect of sulforaphane on cell growth, G(o)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells [J]. Int J Oncol, 2006, 29(4): 883-888.
25. Chiao JW, Wu H, Ramaswamy G, et al. A diet of an isothiocyanate metabollte from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest [J].AACR Meeting Abstracts, 2004, 2004: 166.
26. Myzak MC, Karplus PA, Chung FL, et al. A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase [J]. Cancer Res, 2004, 64: 5767-5774.
27. Myzak MC, Tong P, Dashwood WM, et al. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human [J]. Subjects Exp Biol Med, 2007, 232: 227-234.
28. Lu LL, Ma XD, Becklemisheva A, et al. Phenolhexyl isothiocyanate, a new histone deacetylase inhibitor, can prevent tumor formation and inhibit leukemia cell growth in vivo [J]. Blood (ASH Annual Meeting Abstracts), 2005, 106: 4625.
29. Beklemisheva AA, Fang Y, Feng J, Ma X, et al. Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells [J]. Anticancer Res, 2006, 26(2A): 1225-1230.
30. Wang LG, Beklemisheva A, Liu XM, et al. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer [J]. Mol Carcinog, 2007, 46(1): 24-31.
31. Uto T, Fujii M, Hou DX. Inhibition of lipopolysacchride-induced cyclooxygenase-2 transcription by 6-(methyl- sulfinyl) hexyl isothiocyanate, a chemopreventive compound from Wasabia japonica (Miq.) Matsumura, in mouse macrophages [J]. Biochem Pharmacol, 2005, 70(12): 1772-84.
32. Heiss K, Herhaus C, Klimo K, et al. Nuclear factor κB is amolecular target for sulforaphane-mediated anti- infammatory mechanisms [J]. Biol Chem, 2001, 276(34): 32008-32015.
33. Kim SJ, Kang SY, Shin HH, et al. Sulforaphane inhibits osteoclastogenesis by inhibiting nuclear factor-kappa B [J]. Mol Cells, 2005, 20(3): 364-370.
34. Wadleigh DJ, Reddy ST, Kopp E, et al. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages[J]. Biol Chem, 2000, 275(9): 6259-6266.
35. Hiramoto M, Shimizu N, Sugimoto K, et al. Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330 [J]. J Immunol, 1998, 160(2): 810-819.
36. Xiao D, Singh SV. Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo [J]. Cancer Res, 2007, 67(5): 2239-46
37. Asakage M, Tsuno NH, Kitayama J, et al. Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis [J]. Angiogenesis, 2006, 9(2): 83-91.
38. Bertl E, Bartsch H, Gerhäuser C. Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention [J]. Mol Cancer Ther, 2006, 5: 575-585.
39. Bodo J, Chovancova J, Hunakova L, et al. Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoate[J]. Neoplasma, 2005, 52(6): 510-516.
40. Wang LG, Liu XM, Chiao JW. Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate [J]. Carcinogenesis, 2006, 27: 2124-2132.
41. Kamath TA, Morris ME. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine [J], Pharm Res, 2002, 19(10): 1509-15.
42. Hu K, MorrisME. Effects of benzyl-, phenethyl-, and alpha-naphthyl isothiocyanates on P-glycoprotein- and MRP1-mediated transport [J]. Pharm Sci, 2004, 93(7): 1901-1911.
43. Ji Y, Morris ME. Membrane transport of dietary phenethyl isothiocyanate by ABCG2 (breast cancer resistance protein) [J]. Mol Pharm, 2005, 2(5): 414-419.
44. Ji Y, Morris ME. Effect of organic isothiocyanates on breast cancer resistance protein (ABCG2)-mediated transport [J]. Pharm Res, 2004, 21(12): 2261-2269.
45. Y Ji, Morris ME. Transport of dietary phenethyl isothiocyanate is mediated by multidrug resistance protein 2 but not P-glycoprotein [J]. Biochem Pharmacol, 2005, 70(4): 640-647.
46. Fimognari C, Lenzi M, Sciuscio D, et al. Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation, signal transduction pathways, part C: cell signaling in health and disease volume 1095 published December 2006,[J], Ann NY Acad Sci, 2007, 1095: 62-69.
47. Manesh C, Kuttan G. Effect of naturally occurring isothiocyanates on the immune system [J]. Immunopharmacol Immunotoxicol, 2003, 25(3): 451-459.
48. Thejass P, Kuttan G. Augmentation of natural killer cell and antibody-dependent cellular cytotoxicity in BALB/c mice by sulforaphane, a naturally occurring isothiocyanate from broccoli through enhanced production of cytokines IL-2 and IFN-gamma [J]. Immunopharmacol Immunotoxicol, 2006, 28(3): 443-457.
49. Thejass P; Kuttan G. Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane [J]. Immunopharmacol Immunotoxicol, 2007, 29(2): 173-186.
50. Haristoy X, Fahey JW, Scholtus I, et al. Evaluation of the antimicrobial effects of several isothiocyanates on Helicobacter pylori [J]. Planta Med, 2005, 71(4): 326-330.
51. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk [J]. Natl Cancer Inst, 2000; 92: 61-68.
52. Cornblatt BS, Ye LX, Dinkova- Kostova AT, et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast [J]. Carcinogenesis, 2007, 28: 1485-1490.
53. Fowke JH, Chung FL, Jin F, et al. Isothiocyanate levels, brassica, and human breast cancer [J]. Cancer Res, 2003, 63: 3980-3986.
54. 105Val genetic polymorphism, and breast cancer risk [J]. Clin Nutr, 2008, 87: 753-760.
55. Moy KA, Yuan JM, Chung FL, et al. Urinary total isothiocyanates and colorectal cancer: a prospective study of men in shanghai, China [J]. Cancer Epidemiol Biomarkers Prev, 2008, 17: 1354-1359.
56. Xiao LY, Ma XD, Huang YQ, et al. The epigenetic effect of phenylhexyl isothiocyanate on histone acetylation in patients with acute leukemia and non-leukemic disorders [J]. Blood (ASH Annual Meeting Abstracts), 2007, 110: 4145.
57. Steele VE. Current mechanistic approaches to the chemoprevention of cancer [J]. Biochem Mol Biol, 2003, 36(1): 78-81.
58. Lippman SM, Benner SE, Hong WK. Cancer chemoprevention[J]. Clin Oncology, 1994, 12(4): 851-.
59. Tsuda H, Ohshima Y, Nomoto H, et al. Cancer prevention by natural compounds [J]. Drug Metab Pharmacokinet, 2004, 19(4): 245-263.
60. Nair S, Li W, Kong AN. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells [J]. Acta Pharmacol Sin, 2007, 28(4): 459-472.